ARCHIVES OF EVENTS
Did not you miss our event? It does not matter, we have a record and a lecture material for you.
20 - 21 November 2019
We were proud to organize the 7th PharmAround Conference, organized by PharmAround, endowment fund in cooperation with Department of Pharmacology - Faculty of Medicine of Masaryk University. The Conference took place on 20–21 November 2019 in hotel Courtyard by Marriott in Brno and were intended mainly for physicians, pharmacists, the pharmaceutical industry, academic workers and other healthcare professionals but as well for patients and patient organisations.
6 June 2019
This event will take place on 6 June 2019 at the Faculty of Medicine of Masaryk University in Brno. The meeting is intended primarily for Clinical Research Study Nurses and Clinical Trial Coordinators from various types of healthcare facilities throughout the Czech Republic. A limited number of vacant seats is intended for project authority delegates, especially clinical monitors, from pharmaceutical companies and CRO.
14 February 2019
We would like to invite you to the 5th Day of Clinical Pharmacy in Brno, this event will take place under the auspices of the PharmAround Endowment Fund in the Masaryk Memorial Cancer Institute´s conference rooms in Brno on 14 February 2019.
Main topics
TDM for a Clinical Pharmacist
Interaction of biochemical determinations and drugs
Genetics and Pharmacotherapy
8 October 2018
We would like to invite you to 6th PharmAround Conference, organized by PharmAround, endowment fund in cooperation with Research Infrastructure CZECRIN.
22 May 2018
CZECRIN (Czech Clinical Infrastructure Network) organizes Clinical Trials Experts meeting in collaboration with PharmAround, endowment fund on the occasion of International Clinical Trials Day.
16 May 2018
Let us invite you to the workshop organised by PharmAround endowment fund and Masaryk Memorial Cancer Institute „Outcome-Based Models“ in reimbursement procedures of innovative oncologic treatment. The workshop will be held on Wednesday, May 16, 2018 at Brno Exhibition Centre pavilon E as part of the 42st Brno Oncology Days Conference.
9.-10.11.2017
We would like to invite you to 5th PharmAround Conference, organized by PharmAround, endowment fund in coorporation with Research Infrastructure CZECRIN. The Conference will be held on 9. – 10. 11. 2017 in hotel CENTRO in Hustopeče u Brna.
23.5.2017
CZECRIN (Czech Clinical Infrastructure Network) organizes Clinical Trials Experts meeting in collaboration with Pharmaround, endowment fund on the occassion of National Clinical Trials day 2017.
26.4.2017
Let us invite you to the workshop organised by PharmAround endowment fund, Masaryk Memorial Cancer Institute and Czecrin „Value-based medicine“ in innovative cancer treatment. The workshop will be held on Wednesday, April 26, 2017 at Brno Exhibition Centre pavilon E as part of the 41st Brno Oncology Days Conference.
13.9.2016
Pharma days is a traditional annual congress of Czech and Slovak pharmacologists.
19.5. - 20.5.2016
ECRIN and CZECRIN to Hold Meetings in Prague during International Clinical Trials Day.
International Clinical Trials Day is celebrated internationally on 20 May every year. The event commemorates the day that James Lind started his famous 1747 scurvy trial, and highlights the importance of clinical trial research to health care.
14.9.2015
PharmAround, endowment fund will support a student or employee of Czech academia by reimbursement of the participation fee for "Introductory ATMP Development Regulatory Course" organized by the EATRIS in cooperation with the Italian National Public Health Institute (ISS, Istituto Superiore di Sanità).
23.4. 2014
Program of the workshop will be submitted in greater details.
2.4. - 4.4.2014
3.12.2013
Main topics of the second panel of lectures focused on the drug life cycle will be linked with clinical trials of the drugs and with medicinal product entering the market. We will discuss marketing authorization of medicinal products and determination of the maximum prices and level and conditions of reimbursement of the medicinal products following from the valid legislation in the Czech Republic.
15.11. - 16.11.2013
Second PharmAround annual conference focused on health technology assessment.
23.10.2013
Afternoon lectures - module 1/ Drug Life Cycle and what shall we understood under this term, and module 2/ Preclinical and Clinical Drug Research and development.
10.10.2013
17.4.2013
21.3.2013
Daylong workshop focused on Health Technology Assessment in CR with representatives of the Ministry of Health of the Czech Republic, State Institute for Drug Control, General Insurance Company.
9.11. - 10.11.2012
6.6.2012
Medicinal Product Advertising, Legislative Standards of Drug Promotion. Ethics and Law.
9.5.2012
The lecture is devoted to the function of pharmacovigilance within the scope of the life cycle of the drug and roles of individual participants of the pharmacovigilance system, i.e. healthcare workers, patients, marketing authorization authorities and marketing authorization holders.
18.4.2012
The process of decision taking concerning the maximum prices and the level and conditions of reimbursement of the medicinal products (MP) takes place in the regime of the administrative proceedings; under the applicable law the health insurance companies and the marketing authorization holders are obliged to participate in these proceedings.
21.3.2012
No medicinal product may be launched without the decision on marketing authorization granted by the national authority or by the European Medicines Agency. Marketing authorization is the basic prerequisite for standard medicinal product entering the market in CR and EU.
15.2.2012
23.5.2017
CZECRIN (Czech Clinical Infrastructure Network) organizes Clinical Trials Experts meeting in collaboration with Pharmaround, endowment fund on the occassion of National Clinical Trials day 2017.
26.4.2017
Let us invite you to the workshop organised by PharmAround endowment fund, Masaryk Memorial Cancer Institute and Czecrin „Value-based medicine“ in innovative cancer treatment. The workshop will be held on Wednesday, April 26, 2017 at Brno Exhibition Centre pavilon E as part of the 41st Brno Oncology Days Conference.
13.9.2016
Pharma days is a traditional annual congress of Czech and Slovak pharmacologists.
19.5. - 20.5.2016
ECRIN and CZECRIN to Hold Meetings in Prague during International Clinical Trials Day.
International Clinical Trials Day is celebrated internationally on 20 May every year. The event commemorates the day that James Lind started his famous 1747 scurvy trial, and highlights the importance of clinical trial research to health care.
14.9.2015
PharmAround, endowment fund will support a student or employee of Czech academia by reimbursement of the participation fee for "Introductory ATMP Development Regulatory Course" organized by the EATRIS in cooperation with the Italian National Public Health Institute (ISS, Istituto Superiore di Sanità).
23.4. 2014
Program of the workshop will be submitted in greater details.
2.4. - 4.4.2014
3.12.2013
Main topics of the second panel of lectures focused on the drug life cycle will be linked with clinical trials of the drugs and with medicinal product entering the market. We will discuss marketing authorization of medicinal products and determination of the maximum prices and level and conditions of reimbursement of the medicinal products following from the valid legislation in the Czech Republic.
15.11. - 16.11.2013
Second PharmAround annual conference focused on health technology assessment.
23.10.2013
Afternoon lectures - module 1/ Drug Life Cycle and what shall we understood under this term, and module 2/ Preclinical and Clinical Drug Research and development.
10.10.2013
17.4.2013
21.3.2013
Daylong workshop focused on Health Technology Assessment in CR with representatives of the Ministry of Health of the Czech Republic, State Institute for Drug Control, General Insurance Company.
9.11. - 10.11.2012
6.6.2012
Medicinal Product Advertising, Legislative Standards of Drug Promotion. Ethics and Law.
9.5.2012
The lecture is devoted to the function of pharmacovigilance within the scope of the life cycle of the drug and roles of individual participants of the pharmacovigilance system, i.e. healthcare workers, patients, marketing authorization authorities and marketing authorization holders.
18.4.2012
The process of decision taking concerning the maximum prices and the level and conditions of reimbursement of the medicinal products (MP) takes place in the regime of the administrative proceedings; under the applicable law the health insurance companies and the marketing authorization holders are obliged to participate in these proceedings.
21.3.2012
No medicinal product may be launched without the decision on marketing authorization granted by the national authority or by the European Medicines Agency. Marketing authorization is the basic prerequisite for standard medicinal product entering the market in CR and EU.
15.2.2012